Key result
The ASK1/p38 signaling pathway negatively regulates physiological hypertrophy, as ASK1-deficient mice showed exaggerated cardiac growth and enhanced Akt activation after 4 weeks of swimming.
The ASK1/p38 signaling pathway acts as a negative regulator of physiological cardiac hypertrophy, suggesting a distinct molecular mechanism from pathological remodeling.
Answers are grounded in this paper and cite their sources.
Caution against clinical extrapolation from mice; leaves open distinct ASK1 roles in human physiological vs pathological hypertrophy.
BACKGROUND: Mechanical stress on the heart can lead to crucially different outcomes. Physiological stimuli such as exercise cause adaptive cardiac hypertrophy, characterized by a normal cardiac structure and normal or enhanced cardiac function. Pathological stimuli such as hypertension and aortic valvular stenosis cause maladaptive cardiac remodeling and ultimately heart failure. Apoptosis signal-regulating kinase 1 (ASK1) is known to be involved in pathological cardiac remodeling, but it has not been determined whether ASK1 pathways coordinate the signaling cascade leading to physiological type cardiac growth. METHODS AND RESULTS: To evaluate the role of ASK1 in the physiological form of cardiac growth, mice lacking ASK1 (ASK1-/-) were exercised by swimming for 4 weeks. ASK1-/- mice showed exaggerated growth of the heart accompanied by typical characteristics of physiological hypertrophy. Their swimming-induced activation of Akt, a key molecule in the signaling cascade of physiological hypertrophy, increased more than that seen in wild-type controls. The activation of p38, a downstream kinase of ASK1, was suppressed selectively in the swimming-exercised ASK1-/- mice. Furthermore, the inhibition of ASK1 or p38 activity enhanced insulin-like growth factor 1-induced protein synthesis in rat neonatal ventricular cardiomyocytes, and the treatment with a specific inhibitor of p38 resulted in enhancement of Akt activation and suppression of protein phosphatase 2A activation. The cardiac-specific p38alpha-deficient mice developed an exacerbated form of cardiac hypertrophy in response to swimming exercise. CONCLUSIONS: These results indicate that the ASK1/p38 signaling pathway negatively regulates physiological hypertrophy.
No takes yet. Share an insight, caveat, or question.
Taniike et al. (2008) studied Physiological cardiac hypertrophy. ASK1 deficiency or p38 inhibition vs. Wild-type controls was evaluated on Cardiac growth and signaling pathway activation. The ASK1/p38 signaling pathway negatively regulates physiological hypertrophy, as ASK1-deficient mice showed exaggerated cardiac growth and enhanced Akt activation after 4 weeks of swimming.
Synapse has enriched 10 related papers. Consider them for comparative context: